The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 82, Issue 3, 2008, Pages 317-323

  Le, Duc Son N T ^a   Miles, Rachelle ^a   Savage, Peter J ^b   Cornell, Elaine ^c   Tracy, Russell P ^c   Knowler, William C ^a   Krakoff, Jonathan ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

Diabetic nephropathy; Diabetic retinopathy; Fibrinogen concentration; Inflammatory and hemostatic markers; Pima Indians; Young onset type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPLASMIN; C REACTIVE PROTEIN; CREATININE; D DIMER; FIBRINOGEN; GLITAZONE DERIVATIVE; GLUCOSE; INTERLEUKIN 6; PLASMIN; PLASMIN ANTIPLASMIN COMPLEX; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIET RESTRICTION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; DRUG USE; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; PROLIFERATIVE RETINOPATHY; SMOKING;

ADULT; ALBUMINS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FIBRINOGEN; HUMANS; INDIANS, NORTH AMERICAN; INFLAMMATION; MICROCIRCULATION;

EID: 55549092397     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.08.019     Document Type: Article

References (34)

1. Fagot-Campagna A., Pettitt D.J., Engelgau M.M., Burrows N.R., Geiss L.S., Valdez R., et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J. Pediatr. 136 (2000) 664-672
2. Mauer S.M., and Chavers B.M. A comparison of kidney disease in type I and type II diabetes. Adv. Exp. Med. Biol. 189 (1985) 299-303
3. Katzeff H.L., Savage P.J., Barclay-White B., Nagulesparan M., and Bennett P.H. C-peptide measurement in the differentiation of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 28 (1985) 264-268
4. Savage P.J., Bennett P.H., Senter R.G., and Miller M. High prevalence of diabetes in young Pima Indians: evidence of phenotypic variation in a genetically isolated population. Diabetes 28 (1979) 937-942
5. Pavkov M.E., Hanson R.L., Knowler W.C., Bennett P.H., Krakoff J., and Nelson R.G. Changing patterns of type 2 diabetes incidence among Pima Indians. Diabetes Care 30 (2007) 1758-1763
6. Pavkov M.E., Bennett P.H., Knowler W.C., Krakoff J., Sievers M.L., and Nelson R.G. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 296 (2006) 421-426
7. Krakoff J., Lindsay R.S., Looker H.C., Nelson R.G., Hanson R.L., and Knowler W.C. Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care 26 (2003) 76-81
8. Le N.T.D.S., Roman M.J., Miles R., Looker H.C., Savage P.J., Reaven P.D., et al. Carotid intima-medial thickness and plaque in young adult Pima Indians with childhood or young adult onset of type 2 diabetes. Diabetes 55 (2006) A159-
9. Miles R.R., Detrano R., Reaven P.D., Pring J., Savage P.J., Hanson R.L., et al. Coronary calcium in Pima Indians with childhood- and young adult onset type 2 diabetes. Circulation 110 (2004) A3845-
10. Pavkov M.E., Bennett P.H., Sievers M.L., Krakoff J., Williams D.E., Knowler W.C., et al. Predominant effect of kidney disease on mortality in Pima Indians with or without type 2 diabetes. Kidney Int. 68 (2005) 1267-1274
11. Fried L., Solomon C., Shlipak M., Seliger S., Stehman-Breen C., Bleyer A.J., et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J. Am. Soc. Nephrol. 15 (2004) 3184-3191
12. van Hecke M.V., Dekker J.M., Nijpels G., Moll A.C., Heine R.J., Bouter L.M., et al. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia 48 (2005) 1300-1306
13. Dalla V.M., Mussap M., Gallina P., Bruseghin M., Cernigoi A.M., Saller A., et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J. Am. Soc. Nephrol. 16 Suppl. 1 (2005) S78-S82
14. Lin J., Hu F.B., Rimm E.B., Rifai N., and Curhan G.C. The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus. Kidney Int. 69 (2006) 336-342
15. Meleth A.D., Agron E., Chan C.C., Reed G.F., Arora K., Byrnes G., et al. Serum inflammatory markers in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 46 (2005) 4295-4301
16. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group (Tech. Rep. Ser., no. 727), 1985.
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 20 (1997) 1183-1197.
18. Klein R., Klein B.E., Magli Y.L., Brothers R.J., Meuer S.M., Moss S.E., et al. An alternative method of grading diabetic retinopathy. Ophthalmology 93 (1986) 1183-1187
19. Knowler W.C., Bennett P.H., and Ballintine E.J. Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. N. Engl. J. Med. 302 (1980) 645-650
20. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
21. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol. 17 (1957) 237-246
22. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 (2004) II2-II10
23. Kunzelman C.L., Knowler W.C., Pettitt D.J., and Bennett P.H. Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney Int. 35 (1989) 681-687
24. Nelson R.G., Wolfe J.A., Horton M.B., Pettitt D.J., Bennett P.H., and Knowler W.C. Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians. Diabetes 38 (1989) 435-440
25. Aso Y., Fujiwara Y., Tayama K., Takebayashi K., Inukai T., and Takemura Y. Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes. Clin. Chim. Acta 301 (2000) 135-145
26. Asakawa H., Tokunaga K., and Kawakami F. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. J. Diab. Complications 14 (2000) 121-126
27. Kedzierska K., Ciechanowski K., Golembiewska E., Safranow K., Ciechanowicz A., Domanski L., et al. Plasma prekallikrein as a risk factor for diabetic retinopathy. Arch. Med. Res. 36 (2005) 539-543
28. Lip P.L., Jones A.F., Price N., Headon M., Beevers D.G., and Lip G.Y. Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy?. Acta Ophthalmol. Scand. 76 (1998) 533-536
29. Erem C., Hacihasanoglu A., Celik S., Ovali E., Ersoz H.O., Ukinc K., et al. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. Med. Princ. Pract. 14 (2005) 22-30
30. Prinsen B.H., Rabelink T.J., Beutler J.J., Kaysen G.A., De Boer J., Boer W.H., et al. Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure. Kidney Int. 64 (2003) 1495-1504
31. Takebayashi K., Suetsugu M., Matsutomo R., Wakabayashi S., Aso Y., and Inukai T. Correlation of high-sensitivity C-reactive protein and plasma fibrinogen with individual complications in patients with type 2 diabetes. South Med. J. 99 (2006) 23-27
32. Palmieri V., Roman M.J., Bella J.N., Liu J.E., Best L.G., Lee E.T., et al. Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: the Strong Heart Study. J. Am. Soc. Echocardiogr. 21 (2008) 66-71
33. Palmieri V., Celentano A., Roman M.J., de Simone G., Best L., Lewis M.R., et al. Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study. Am. Heart J. 145 (2003) 467-474
34. Looker H.C., Fagot-Campagna A., Gunter E.W., Pfeiffer C.M., Narayan K.M., Knowler W.C., et al. Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia 46 (2003) 766-772